Neurocircuitry Mechanisms and Efficacy of Lumateperone as Adjunctive Therapy for Major Depressive Disorder and History of Early Life Abuse

Summary

The purpose of this clinical research study is to understand how effective and safe an investigational study drug called lumateperone is and whether it works to reduce the severity of depressive symptoms in adults with Major Depressive Disorder (MDD) and early life trauma. The main questions it aims to answer are: Aim 1: To assess the efficacy of lumateperone 42 mg administered once daily compared with placebo in the treatment of patients with Major Depressive Disorder and early life abuse. Aim 2: To assess neurocircuitry encoding of threat and reward learning as predictors of lumateperone response and as mechanisms of treatment action, and assess the change from pre-dose to post-dose of task-evoked brain activation.

Timeline

Start

2026-02

Primary completion

2030-01

Completion

2030-01

Publications

• Background Dziura JD, Post LA, Zhao Q, Fu Z, Peduzzi P. Strategies for dealing with missing data in clinical trials: from design to analysis. Yale J Biol Med. 2013 Sep 20;86(3):343-58. eCollection 2013 Sep.
• Background van Buuren, S., & Groothuis-Oudshoorn, K. (2011). mice: Multivariate Imputation by Chained Equations in R. Journal of Statistical Software, 45(3), 1-67. https://doi.org/10.18637/jss.v045.i03
• Background Waddell L, Taylor M. A new self-rating scale for detecting atypical or second-generation antipsychotic side effects. J Psychopharmacol. 2008 May;22(3):238-43. doi: 10.1177/0269881107087976.
• Background Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011 Dec;168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704.
• Background Guy W (ed). ECDEU Assessment Manual for Psychopharmacology. Clinical Global Impressions (CGI). 1976. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Alcohol Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch, pp. 218-222.
• Background Williams JB, Kobak KA. Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA). Br J Psychiatry. 2008 Jan;192(1):52-8. doi: 10.1192/bjp.bp.106.032532.
• Background First MB, Williams JBW, Benjamin LS, Spitzer RL: User's Guide for the SCID-5-PD (Structured Clinical Interview for DSM-5 Personality Disorder). Arlington, VA, American Psychiatric Association, 2015
• Background Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Ther. 2010 Oct;16(5):322-5. doi: 10.1111/j.1755-5949.2009.00102.x.
• Background Tolin DF, Gilliam C, Wootton BM, Bowe W, Bragdon LB, Davis E, Hannan SE, Steinman SA, Worden B, Hallion LS. Psychometric Properties of a Structured Diagnostic Interview for DSM-5 Anxiety, Mood, and Obsessive-Compulsive and Related Disorders. Assessment. 2018 Jan;25(1):3-13. doi: 10.1177/1073191116638410. Epub 2016 Mar 17.
• Background Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, Keane TM, Marx BP. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychol Assess. 2018 Mar;30(3):383-395. doi: 10.1037/pas0000486. Epub 2017 May 11.
• Background Meltzer HY, Huang M. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Prog Brain Res. 2008;172:177-97. doi: 10.1016/S0079-6123(08)00909-6.
• Background Meltzer HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology. 1999 Aug;21(2 Suppl):106S-115S. doi: 10.1016/S0893-133X(99)00046-9.
• Background Hiser J, Heilicher M, Botsford C, Crombie KM, Bellani J, Azar A, Fonzo G, Nacewicz BM, Cisler JM. Decision-making for concurrent reward and threat is differentially modulated by trauma exposure and PTSD symptom severity. Behav Res Ther. 2023 Aug;167:104361. doi: 10.1016/j.brat.2023.104361. Epub 2023 Jun 28.
• Background Weaver SS, Kroska EB, Ross MC, Sartin-Tarm A, Sellnow KA, Schaumberg K, Kiehl KA, Koenigs M, Cisler JM. Sacrificing reward to avoid threat: Characterizing PTSD in the context of a trauma-related approach-avoidance conflict task. J Abnorm Psychol. 2020 Jul;129(5):457-468. doi: 10.1037/abn0000528. Epub 2020 May 21.
• Background Moughrabi N, Botsford C, Gruichich TS, Azar A, Heilicher M, Hiser J, Crombie KM, Dunsmoor JE, Stowe Z, Cisler JM. Large-scale neural network computations and multivariate representations during approach-avoidance conflict decision-making. Neuroimage. 2022 Dec 1;264:119709. doi: 10.1016/j.neuroimage.2022.119709. Epub 2022 Oct 22.
• Background Ironside M, Amemori KI, McGrath CL, Pedersen ML, Kang MS, Amemori S, Frank MJ, Graybiel AM, Pizzagalli DA. Approach-Avoidance Conflict in Major Depressive Disorder: Congruent Neural Findings in Humans and Nonhuman Primates. Biol Psychiatry. 2020 Mar 1;87(5):399-408. doi: 10.1016/j.biopsych.2019.08.022. Epub 2019 Sep 6.
• Background Pedersen ML, Ironside M, Amemori KI, McGrath CL, Kang MS, Graybiel AM, Pizzagalli DA, Frank MJ. Computational phenotyping of brain-behavior dynamics underlying approach-avoidance conflict in major depressive disorder. PLoS Comput Biol. 2021 May 10;17(5):e1008955. doi: 10.1371/journal.pcbi.1008955. eCollection 2021 May.
• Background Cisler JM, Esbensen K, Sellnow K, Ross M, Weaver S, Sartin-Tarm A, Herringa RJ, Kilts CD. Differential Roles of the Salience Network During Prediction Error Encoding and Facial Emotion Processing Among Female Adolescent Assault Victims. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Apr;4(4):371-380. doi: 10.1016/j.bpsc.2018.08.014. Epub 2018 Sep 11.
• Background Ross MC, Lenow JK, Kilts CD, Cisler JM. Altered neural encoding of prediction errors in assault-related posttraumatic stress disorder. J Psychiatr Res. 2018 Aug;103:83-90. doi: 10.1016/j.jpsychires.2018.05.008. Epub 2018 May 12.
• Background Cisler JM, Tamman AJF, Fonzo GA. Diminished prospective mental representations of reward mediate reward learning strategies among youth with internalizing symptoms. Psychol Med. 2023 Oct;53(14):6910-6920. doi: 10.1017/S0033291723000478. Epub 2023 Mar 7.
• Background Keren H, O'Callaghan G, Vidal-Ribas P, Buzzell GA, Brotman MA, Leibenluft E, Pan PM, Meffert L, Kaiser A, Wolke S, Pine DS, Stringaris A. Reward Processing in Depression: A Conceptual and Meta-Analytic Review Across fMRI and EEG Studies. Am J Psychiatry. 2018 Nov 1;175(11):1111-1120. doi: 10.1176/appi.ajp.2018.17101124. Epub 2018 Jun 20.
• Background Webb CA, Murray L, Tierney AO, Forbes EE, Pizzagalli DA. Reward-related predictors of symptom change in behavioral activation therapy for anhedonic adolescents: a multimodal approach. Neuropsychopharmacology. 2023 Mar;48(4):623-632. doi: 10.1038/s41386-022-01481-4. Epub 2022 Oct 28.
• Background Huys QJ, Pizzagalli DA, Bogdan R, Dayan P. Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis. Biol Mood Anxiety Disord. 2013 Jun 19;3(1):12. doi: 10.1186/2045-5380-3-12.
• Background Hedtke KA, Ruggiero KJ, Fitzgerald MM, Zinzow HM, Saunders BE, Resnick HS, Kilpatrick DG. A longitudinal investigation of interpersonal violence in relation to mental health and substance use. J Consult Clin Psychol. 2008 Aug;76(4):633-47. doi: 10.1037/0022-006X.76.4.633.
• Background Lippard ETC, Nemeroff CB. The Devastating Clinical Consequences of Child Abuse and Neglect: Increased Disease Vulnerability and Poor Treatment Response in Mood Disorders. Am J Psychiatry. 2023 Aug 1;180(8):548-564. doi: 10.1176/appi.ajp.19010020.
• Background Nemeroff CB. Paradise Lost: The Neurobiological and Clinical Consequences of Child Abuse and Neglect. Neuron. 2016 Mar 2;89(5):892-909. doi: 10.1016/j.neuron.2016.01.019.

Drugs

Indications